NCT00481390 - Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients | Biotech Hunter

Enrollment

1,110

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Infection, Human Immunodeficiency Virus IHIV InfectionHIV-1 Infection

Interventions

PROCEDURE

Cheek cells sample

PROCEDURE

Blood sample

Trial Locations (20)

8

GSK Investigational Site, Dublin

1011

GSK Investigational Site, Lausanne

1150

GSK Investigational Site, Lisbon

3010

GSK Investigational Site, Bern

6900

GSK Investigational Site, Lugano

8030

GSK Investigational Site, Zurich

8091

GSK Investigational Site, Zurich

00029

GSK Investigational Site, Helsinki

1815 JD

GSK Investigational Site, Alkmaar

1105 AZ

GSK Investigational Site, Amsterdam

6815 AD

GSK Investigational Site, Arnhem

7511JX

GSK Investigational Site, Enschede

9713 GZ

GSK Investigational Site, Groningen

6229 HX

GSK Investigational Site, Maastricht

3015 GD

GSK Investigational Site, Rotterdam

3078 HT

GSK Investigational Site, Rotterdam

2512 VA

GSK Investigational Site, The Hague

2545 CH

GSK Investigational Site, The Hague

2720-276

GSK Investigational Site, Amadora

CH 2301

GSK Investigational Site, La Chaux-de-Fonds